Study identifies a genetic link to susceptibility and resistance to inflammatory bowel disease

April 13, 2017
Inflammatory Bowel Diseases study

Inflammatory bowel disease (IBD), characterized by chronic relapsing inflammation of the gut, is a common problem in the industrialized world. However, how IBD develops remains unknown. There is currently no cure and treatment options are costly and limited to alleviating symptoms. A new study in The American Journal of Pathology reveals that the Cd14 gene is a protective factor in experimental inflammatory bowel disease by enhancing the intestinal barrier function.

It is well known that patients' genetics as well as microbial factors contribute to IBD. Researchers identified Cd14 in a genetic screen in a mouse model system for IBD. They showed that the Cd14 molecule plays a protective role in their model system of intestinal function in mice. Mice with Cd14 deficiency developed more severe inflammation of the gut with destabilization of the intestinal barrier compared to controls, whereas stimulation of Cd14 expression strengthened the barrier's integrity.

"Our understanding of the microbiome and its interaction with host genetic factors is increasing dramatically, especially in the pathogenesis of IBD. Cd14 is involved in the detection of bacterial factors and has been identified as a candidate gene in genetic screens. Our study helps to understand the link between genetic susceptibility and microbial alterations in the gut in IBD," explained lead investigator André Bleich, PhD, Professor and Director, Institute for Laboratory Animal Science, Hannover Medical School, Hannover (Germany).

As a part of the innate immune system, Cd14 helps the body respond to bacterial infections by producing a protein that binds to lipopolysaccharides within the outer membranes of some bacteria. The protein can be found attached to cell surfaces or secreted in soluble form. The Cd14 protein is found among different cell types, including epithelia, blood, and dendritic cells. In mice, Cd14 levels can depend upon the strain of mice and the location of the tissue, with the highest concentration found in the furthest portions of the intestine, which contain the greatest number of bacteria.

Investigators examined the effects of Cd14 deficiency on intestinal function and studied both an acute and chronic model of colitis. In the acute model, the Cd14-deficient mice showed greater weight reduction and intestinal barrier disruption than controls, including more severe intestinal lesions and ulcerations. They also secreted higher amounts of inflammatory cytokines—interferon-? and tumor necrosis factor-α. "Cd14 seems to play a pivotal role in the maintenance of barrier integrity. Further analyses suggested that the presence of Cd14 becomes even more important when the epithelial layer is disturbed rather than during steady-state conditions," commented Dr. Bleich.

In contrast, stimulation of Cd14 expression played a protective role on the intestine. After administration of zinc, which increases Cd14 levels in a transgenic mouse model, the investigators found less inflammation in the colon and reduced levels of pro-inflammatory cytokines.

According to Dr. Bleich and his co-investigators, "Epithelial barrier function is predominantly dependent on tight junction proteins, which regulate transport into and between cells. Loss of gut barrier integrity, initiated by bacteria or by treatment with a chemical, can result in bacterial invasion and inflammation. Pro-inflammatory cytokines also cause dysregulation of permeability during inflammation. Our work provides evidence that Cd14 is pivotal for regulating tight junction proteins by reducing the expression of pro-inflammatory cytokine. Our findings suggest that soluble Cd14 could be an interesting new therapeutic target for future clinical research."

Explore further: Understanding the origins and function of CD14+ immune cells

More information: Stephanie Buchheister et al, CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function, The American Journal of Pathology (2017). DOI: 10.1016/j.ajpath.2017.01.012

Related Stories

Understanding the origins and function of CD14+ immune cells

February 4, 2015
Dendritic cells and macrophages are immune cells that orchestrate diverse immune functions within many body tissues, including the skin. New work by A*STAR researchers and colleagues shows that CD14+ cells in the skin—long ...

Intestinal macrophages in liver cirrhosis produce NO, disrupt intestinal barrier function

April 19, 2012
A South African study presented today determines the importance of bacterial infections, which commonly occur in cirrhosis and can alter the natural history of the condition, possibly leading to loss of liver function and ...

Gut microbes contribute to age-associated inflammation, mouse study finds

April 12, 2017
Inflammation increases with age and is a strong risk factor for death in the elderly, but the underlying cause has not been clear. A study published April 12 in Cell Host & Microbe reveals that gut microbes are one of the ...

Newly discovered bacteria-binding protein in the intestine

December 8, 2016
Deficiency in a certain protein in the gastrointestinal tract has been shown to lead to both inflammation and abdominal fat accumulation in mice. The discovery provides yet another piece of the puzzle of how humans are affected—or ...

Mechanism for inhibiting bacterial invasion of colonic epithelia elucidated

May 25, 2016
A group of researchers at Osaka University elucidated how a gene named Ly6/Plaur domain containing 8 (Lypd8) inhibits bacterial invasion of colonic epithelia, regulating intestinal inflammation. This achievement may lead ...

Epigenetic enzyme found to be lacking in some patients with Crohn's disease

March 3, 2017
A Massachusetts General Hospital (MGH) research team has found how a variant in an important epigenetic enzyme—previously associated by population-based genetic studies with Crohn's disease and other immune disorders—interferes ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.